CSIMarket Company Name, Ticker, Competitors, else..
 
Intellia Therapeutics Inc   (NASDAQ: NTLA)
 

NTLA's Market share relative to its competitors, as of Q3 2026

As of Q3 2026 (Revenue in Millions of $)

Date modified: 2026-09-11T13:29:05+00:00




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

COMPANY NAME REVENUES
12 Months Ending
Q3 2026		 MARKET SHARE
12 Months
Q3 2026		 MARKET SHARE
MRQ
Q3 2026		 MARKET SHARE
A Quarter Before
Q2 2026
Intellia Therapeutics Inc 52.89 0.02% 0.01 % 0.01 %
Prime Medicine Inc 4.07 0.00% 0.00% 0.00%
Uniqure N v 18.67 0.01% 0.01% 0.00%
Caribou Biosciences Inc 10.04 0.00% 0.00% 0.00%
Alnylam Pharmaceuticals Inc 5,013.24 2.03% 2.27% 0.84%
Editas Medicine Inc 47.01 0.02% 0.02% 0.00%
40 more competitors available

Sign in to see all competitors for Intellia Therapeutics Inc .

Sign In Create Free Account



NTLA's Market share relative to its competitors, as of Q3 2026 within the In Vitro & In Vivo Diagnostic Substances Industry
As of Q3 2026



COMPANY NAME MARKET SHARE
12 Months Ending
Q3 2026		 MARKET SHARE
12 Months Ending
Q2 2026		 MARKET SHARE
MRQ
Q3 2026		 MARKET SHARE

Q2 2026
Intellia Therapeutics Inc 90.13% 92.12% 100.00 % 99.71 %
Celldex Therapeutics inc 9.87% 7.88% 0.00% 0.29%



NTLA's Market share relative to its competitors, as of Q3 2026 within the Healthcare Sector
As of Q3 2026



COMPANY NAME MARKET SHARE
12 Months Ending
Q3 2026		 MARKET SHARE
12 Months Ending
Q2 2026		 MARKET SHARE
MRQ
Q3 2026		 MARKET SHARE

Q2 2026
Intellia Therapeutics Inc 0.02% 0.01% 0.01 % 0.01 %
Prime Medicine Inc 0.00% 0.00% 0.00% 0.00%
Uniqure N v 0.01% 0.00% 0.01% 0.00%
Caribou Biosciences Inc 0.00% 0.00% 0.00% 0.00%
Alnylam Pharmaceuticals Inc 2.03% 0.79% 2.27% 0.84%
Editas Medicine Inc 0.02% 0.01% 0.02% 0.00%
40 more companies available

Sign in to see all sector competitors for Intellia Therapeutics Inc .

Sign In Create Free Account



Note: Market share is calculated based on total revenue. To get a more accurate picture of Intellia Therapeutics Inc's market divisions, geographic dispersion, segments, products, and services, visit Intellia Therapeutics Inc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.